Advisory Services Network’s Ironwood Pharmaceuticals IRWD Stock Holding History

Advisory Services Network’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$825	Buy	+235	New	+$963	﹤0.01%	4350
2024 Q1	–	Sell	-2,118	Closed	-$24.2K	–	2560
2023 Q4	$24.2K	Buy	+2,118	New	+$20.9K	﹤0.01%	2417
2023 Q2	–	Sell	-2,633	Closed	-$27.7K	–	2534
2023 Q1	$27.7K	Sell	2,633 -380	-13%	-$4.26K	﹤0.01%	2359
2022 Q4	$37.3K	Buy	+3,013	New	+$34.2K	﹤0.01%	2135
2021 Q3	–	Sell	-100	Closed	-$1K	–	2331
2021 Q2	$1K	Buy	+100	New	+$1.15K	﹤0.01%	3474
2021 Q1	–	Sell	-100	Closed	-$1K	–	2144
2020 Q4	$1K	Sell	100 -5	-5%	-$55	﹤0.01%	3155
2020 Q3	$1K	Buy	+105	New	+$1.04K	﹤0.01%	3335
2020 Q2	–	Sell	-100	Closed	-$1K	–	1894
2020 Q1	$1K	Buy	+100	New	+$1.18K	﹤0.01%	2893

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Advisory Services Network's IRWD Position: Q1 2026 in Review

Advisory Services Network opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 235 shares worth $825. The stake represents ﹤0.01% of the portfolio and ranks #4350 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in IRWD as recently as Q4 2023.

Advisory Services Network first reported a position in IRWD in Q1 2020 and has held it in 8 quarters since. The position peaked at $37.3K in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Advisory Services Network held 235 shares of Ironwood Pharmaceuticals worth $825 as of Q1 2026.
Ironwood Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4350 holding.
Advisory Services Network first reported a position in Ironwood Pharmaceuticals in Q1 2020 and has held it in 8 quarters since.
Advisory Services Network's Ironwood Pharmaceuticals position peaked at $37.3K in Q4 2022.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.